Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis

References

• Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988–994. Am J Kidney Dis 2002;40:37-42
   PubMed Web of Science ®Google Scholar
• Porter RS, Kaplan JL, Homeier BP, et al., eds. The Merck Manual, 2008. Whitehouse Station, NJ: Merck Research Laboratories. Available as part of The Merck Manuals Online Medical Library, at: http://www.merck.com/mmpe/index.html [Last accessed 25 February 2008].
   Google Scholar
• Pittman JR, Bross MH. Diagnosis and management of gout. Am Fam Physician 1999;59:1799-806, 1810
   PubMed Web of Science ®Google Scholar
• Schlesinger N. Diagnosis of gout: clinical, laboratory, and radiologic findings. Am J Manag Care 2005;11(15 Suppl):S443-50
   Web of Science ®Google Scholar
• Riedel AA, Nelson M, Joseph-Ridge N, et al. Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims. J Rheumatol 2004;31:1575-81
   PubMed Web of Science ®Google Scholar
• Borstad GC, Bryant LR, Abel MP, et al. Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis. J Rheumatol 2004;31:2429-32
   PubMed Web of Science ®Google Scholar
• Cannella AC, Mikuls TR. Understanding treatments for gout. Am J Manag Care 2005;11(15 Suppl):S451-8
   Web of Science ®Google Scholar
• Lacy CF, Armstrong LL, Goldman MP, et al. Drug Information Handbook, 14th edn. Hudson, OH: Lexi-Comp, 2006
   Google Scholar
• McEvoy GK, ed. AHFS Drug Information® (2006). Available via STAT! Ref Online Electronic Medical Library, at: http://online.statref.com/document.aspx?fxid=1&docid=1230
   Google Scholar
• Kim KY, Schumacher R, Hunsche E, et al. A literature review of the epidemiology and treatment of acute gout. Clin Ther 2003;25:1593-617
   PubMed Web of Science ®Google Scholar
• Wu EQ, Patel PA, Yu AP, et al. Disease-related and all-cause health care costs of elderly patients with gout. J Manag Care Pharm 2008;14:164-75
   PubMed Web of Science ®Google Scholar
• Brook RA, Kleinman NL, Patel PA, et al. The economic burden of gout on an employed population. Curr Med Res Opin 2006;22:1381-9
   PubMed Web of Science ®Google Scholar
• Kleinman NL, Brook RA, Patel PA, et al. The impact of gout on work absence and productivity. Value Health 2007;10:231-7
   PubMed Web of Science ®Google Scholar
• Brixner DI, Ho MJ. Clinical, humanistic, and economic outcomes of gout. Am J Manag Care 2005;11:S459-64
   PubMed Web of Science ®Google Scholar
• Rizzo JA, Simons WR. Variations in compliance among hypertensive patients by drug class: implications for health care costs. Clin Ther 1997;19:1446-57
   PubMed Web of Science ®Google Scholar
• Wortmann RL. Gout and other disorders of purine metabolism. In: Harrison TR, Fauci AS, eds. Harrison's Principles of Internal Medicine, 14th edn. New York, NY: McGraw-Hill, 1998
   Google Scholar
• Emerson BT. The management of gout. N Engl J Med 1996;334:445-51
   PubMed Web of Science ®Google Scholar
• Li-Yu J, Clayburne G, Steck M, et al. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout? J Rheumatol 2001;28:577-80
   Google Scholar
• Shoji A, Yamanaka H, Kamatani N. A retrospective study of the relationship between serum urate level and recurrent attack of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum 2004;51:321-5
   PubMed Web of Science ®Google Scholar
• Terkeltaub RA. Clinical practice. Gout. N Engl J Med 2003;349:1647-55
   PubMed Web of Science ®Google Scholar
• Halpern R, Fuldeore MJ, Mody, RR, et al. The effect of serum urate on gout flares and their associated costs: an administrative claims analysis. J Clin Rheumatol 2009;15:3-7
   PubMed Web of Science ®Google Scholar
• Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administration data. Med Care 1998;36:8-27
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality. Comorbidity Software, Version 3.0. Available at: http://www.hcup-us.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp. [Last accessed 6 August 2008].
   Google Scholar
• StataCorp. 2003. Stata Statistical Software: Release 8.0. College Station, TX: Stata Corporation.
   Google Scholar
• Vawter RL, Antonelli MAS. Rational treatment of gout. Postgrad Med 1992;91:115-16, 118, 127
   PubMed Web of Science ®Google Scholar
• Mikuls TR, Farrar JT, Bilker WB, et al. Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis 2005;64:267-72
   PubMed Web of Science ®Google Scholar
• de Klerk E, van der Heijde D, Landewé R, et al. Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout. J Rheumatol 2003;30:44-54
   PubMed Web of Science ®Google Scholar
• Neogi T, Hunter DJ, Chaisson CE, et al. Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study. J Rheumatol 2006;33:104-9
   PubMed Web of Science ®Google Scholar
• Mikuls TR, Curtis JR, Allison JJ, et al. Medication errors with the use of allopurinol and colchicines: a retrospective study of a national, anonymous internet-accessible error reporting system. J Rheumatol 2006;33:562-6
   PubMed Web of Science ®Google Scholar
• Mikuls TR, Farrar JT, Bilker WB, et al. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results for the UK General Practice Research Database (GPRD). Rheumatology 2005;44:1038-42
   PubMed Web of Science ®Google Scholar